Top AI Product

If you’ve been hanging out in [r/MachineLearning](https://www.reddit.com/r/MachineLearning/) or [r/LocalLLaMA](https://www.reddit.com/r/LocalLLaMA/) this week, you’ve probably seen the buzz around [Evo 2](https://arcinstitute.org/tools/evo). And honestly, after digging into what this thing actually does, I think the hype is justified.

Evo 2 is a DNA foundation model built by Arc Institute and NVIDIA, and it just got its [Nature paper](https://www.nature.com/articles/s41586-026-10176-5) published. Not a preprint, not a blog post — a full Nature publication. That alone should tell you something. The model was trained on 9.3 trillion nucleotides from over 128,000 genomes spanning bacteria, archaea, and eukaryotes. Basically every branch of the tree of life. It has 40 billion parameters and can chew through sequences up to 1 million nucleotides in a single pass, which is kind of wild when you think about how long most genomes actually are.

What really caught my attention is the practical side. Without any fine-tuning, Evo 2 can classify BRCA1 gene variants — the ones linked to breast cancer risk — with over 90% accuracy. That’s not a toy benchmark. That’s clinically relevant mutation prediction straight out of the box. It can also predict pathogenic noncoding mutations, which is a notoriously hard problem in genomics.

The whole thing is [open source on GitHub](https://github.com/ArcInstitute/evo2), including training data, inference code, and model weights. They trained it on over 2,000 NVIDIA H100 GPUs through DGX Cloud, and it’s also available as an NVIDIA BioNeMo NIM microservice if you don’t want to run it locally. The team brought together researchers from Stanford, UC Berkeley, and UCSF, so the institutional backing is solid.

I saw it trending on [llm-stats.com/ai-news](https://llm-stats.com/ai-news) and Phys.org picked it up too. SynBioBeta called it [“one bio-AI model to rule them all”](https://www.synbiobeta.com/read/evo2-one-bio-ai-model-to-rule-them-all), which is a bit dramatic but not entirely wrong. As someone who’s been following the intersection of AI and biology, this feels like the moment genomic AI goes from niche academic tool to something with real-world legs. If you’re into synthetic biology, variant interpretation, or just want to see what a truly large-scale biological model looks like, Evo 2 is worth your time.